Breaking News
CN Bio
About CN Bio
CN Bio Innovations is a pioneer in the development of Organ-on-Chip platforms which enable the discovery of better, safer medicines for serious human diseases.
Our advantage comes from having had almost unparalleled resources to invest in the development of leading edge organ-chips thanks to more than $32 Million in grants and contracts from DARPA, NIH, EU FP7, Innovate UK and NC3Rs.
These programs have led to the development of a 7-organ human body-on-a-chip model (DARPA), a liver-on-a-chip model of cancer metastasis (NIH), a full viral lifecycle organ-chip model of hepatitis B and a liver-on-a-chip model of non-alcoholic fatty liver disease and steatohepatitis (NAFLD/NASH).
CN Bio is at the forefront of translating these promising technologies from leading academic laboratories into the hands of pharmaceutical researchers for the development of new medicines to treat and cure disease, and to the wider academic community seeking to understand biology and disease pathology using technologies which more closely represent the human response.
CN Bio Appoints Dr. Samantha Macro as Chief Financial Officer
June 6 2023
CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems […]
CN Bio Appoints Dr Paul Brooks as Chief Executive Officer
December 20 2022
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems […]
CN Bio Opens New Laboratory Facilities to Extend Organ-on-a-chip Contract Research Services Capabilities
July 19 2022
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems […]
CN Bio Introduces Physiomimix NASH ‘in-a-box’ Reagent Kit
April 26 2022
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological […]
CN Bio and iiCON Announce COVID-19 Research Collaboration
November 9 2021
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological […]
CN Bio Expands Service Offering to Support Oncology Drug Discovery
October 5 2021
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological […]